Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...

Praluent has a list price of more than $14,000 a year. However, Express Scripts customers will be able to receive the drug for $4,500 to $6,600 annually after discounts and rebates, Express Scripts ...

As pharmacy benefit managers (PBMs) face more scrutiny about their practices and rising drug costs, Express Scripts unveiled new solutions last week that aim to improve price transparency and drive ...

Express Scripts ClearNetwork SM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. ST. LOUIS, Nov. 14, 2023 ...

In a lawsuit filed this week, Ohio Attorney General Dave Yost accused pharmacy benefit managers Express Scripts and Prime Therapeutics of using a little-known company based in Switzerland to drive up ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) shares jumped 13% in after-hours trading after it announced that Cigna's Express Scripts plans to list its drug Inpefa as a preferred product on Medicare national ...

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found. By Chris Hamby New legislation would force ...

LOS ANGELES (Reuters) - Express Scripts , the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical ...

Express Scripts ClearNetworkSM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. "We are constantly innovating to ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. By Reed Abelson and ...